|1.||Thati, Bhumika: 2 articles (05/2007 - 04/2007)|
|2.||Walsh, Maureen: 2 articles (05/2007 - 04/2007)|
|3.||Devereux, Michael: 2 articles (05/2007 - 04/2007)|
|4.||Noble, Andy: 2 articles (05/2007 - 04/2007)|
|5.||McCann, Malachy: 2 articles (05/2007 - 04/2007)|
|6.||Egan, Denise A: 2 articles (05/2007 - 04/2007)|
|7.||Creaven, Bernadette S: 2 articles (05/2007 - 04/2007)|
|8.||Kavanagh, Kevin: 2 articles (05/2007 - 04/2007)|
|9.||Ye, Fei: 1 article (05/2015)|
|10.||Jin, Xiaodong: 1 article (05/2015)|
05/18/2007 - "Previously our research group has studied the anti-proliferative effects of a series of hydroxylated derivatives and silver (I) complexes of coumarin-3-carboxylic acid (C-3-COOH) using two human-derived carcinoma cell lines (A-498 and Hep-G2). "
04/18/2007 - "In vitro anti-tumour and cyto-selective effects of coumarin-3-carboxylic acid and three of its hydroxylated derivatives, along with their silver-based complexes, using human epithelial carcinoma cell lines."
04/18/2007 - "The chemotherapeutic potential of coumarin-3-carboxylic acid (C-3-COOH) and a series of three hydroxylated coumarin-3-carboxylic acid ligands, namely 6-hydroxy-coumarin-3-carboxylic acid (6-OH-C-3-COOH), 7-hydroxy-coumarin-3-carboxylic acid (7-OH-C-3-COOH) and 8-hydroxy-coumarin-3-carboxylic acid (8-OH-C-3-COOH), along with their corresponding silver-based complexes, namely 6-hydroxycoumarin-3-carboxylatosilver (6-OH-C-COO-Ag), 7-hydroxycoumarin-3-carboxylatosilver (7-OH-C-COO-Ag) and 8-hydroxycoumarin-3-carboxylatosilver (8-OH-C-COO-Ag), was determined using two human-derived carcinoma (A-498 and Hep-G2), along with two non-carcinoma human-derived cell lines (CHANG and HK-2). "
05/01/2015 - "We examined the dependence of hydroxyl radical production on the concentration of 15 nm citrate-capped AuNPs and dose using coumarin-3-carboxylic acid in phosphate buffered saline (PBS), and investigated the radiosensitisation of different concentration AuNPs on human cervix carcinoma HeLa cells through clonogenic survival assay for X-rays and carbon ions. "
|2.||Melanoma (Melanoma, Malignant)
07/20/2007 - "The first asymmetric total synthesis of (-)-Linderol A, a potent inhibitor of melanin biosynthesis of cultured B-16 melanoma cells, has been achieved via two key reactions: a diastereoselective [2+2] photocycloaddition of a coumarin-3-carboxylate bearing a chiral auxiliary with 3-methyl-1-butene and a subsequent stereoconvergent transformation of the photoadducts with use of dimethylsulfoxonium methylide to afford a tetrahydrodibenzofuran derivative."
|3.||Lung Neoplasms (Lung Cancer)
|2.||Citric Acid (Citrate)
|4.||Valproic Acid (Valproate, Semisodium)